SFM
WINT

Sphera Funds Management’s Windtree Therapeutics Inc WINT Stock Holding History

Sphera Funds Management’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-34,679
Closed -$893K – 160
2014
Q3 		$893K Sell
34,679
-1,035
-3% -$25K 0.11% 111
2014
Q2 		$890K Hold
35,714
– – 0.22% 81
2014
Q1 		$1.07M Hold
35,714
– – 0.25% 88
2013
Q4 		$1.13M Buy
+35,714
New +$1.12M 0.31% 73

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return

Sphera Funds Management's WINT Position: Q4 2014 in Review

Sphera Funds Management sold out of Windtree Therapeutics Inc (WINT) in Q4 2014, closing a stake of 34,679 shares — an estimated $893K sold.

Sphera Funds Management first reported a position in WINT in Q4 2013 and held it in 4 quarters. The position peaked at $1.13M in Q4 2013. 56 funds tracked by Wall St. Rank hold WINT as of Q4 2014.

  • Sphera Funds Management reported no remaining Windtree Therapeutics Inc position as of Q4 2014 after selling out during the quarter.
  • Sphera Funds Management sold 34,679 Windtree Therapeutics Inc shares in Q4 2014, an estimated $893K.
  • Sphera Funds Management first reported a position in Windtree Therapeutics Inc in Q4 2013 and held it in 4 quarters.
  • Sphera Funds Management's Windtree Therapeutics Inc position peaked at $1.13M in Q4 2013.
  • 56 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2014.

Based on Sphera Funds Management's 13F filing for Q4 2014, filed 12 Feb 2015.